{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:10:03Z","timestamp":1789384203507,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T00:00:00Z","timestamp":1179100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T00:00:00Z","timestamp":1179100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1038\/sj.bmt.1705696","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T12:04:07Z","timestamp":1179144247000},"page":"79-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease"],"prefix":"10.1038","volume":"40","author":[{"given":"F","family":"Dignan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Gujral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ethell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Treleaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Potter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,14]]},"reference":[{"key":"BF1705696_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"GB McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118: 255\u2013267.","journal-title":"Ann Intern Med"},{"key":"BF1705696_CR2","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1200\/JCO.1993.11.9.1729","volume":"11","author":"SI Bearman","year":"1993","unstructured":"Bearman SI, Anderson GL, Mori M, Hinds MS, Shulman HM, McDonald GB . Veno-occlusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Onc 1993; 11: 1729\u20131736.","journal-title":"J Clin Onc"},{"key":"BF1705696_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-2002-23204","volume":"22","author":"LD Deleve","year":"2002","unstructured":"Deleve LD, Shulman HM, McDonald GB . Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22: 27\u201342.","journal-title":"Semin Liver Dis"},{"key":"BF1705696_CR4","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/hep.1840190515","volume":"19","author":"HM Shulman","year":"1994","unstructured":"Shulman HM, Fisher LB, Schoch HG, Henne KW, McDonald GB . Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 1994; 19: 1171\u20131181.","journal-title":"Hepatology"},{"key":"BF1705696_CR5","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1182\/blood.V89.6.2184","volume":"89","author":"C Salat","year":"1997","unstructured":"Salat C, Holler E, Kolb HJ, Reinhardt B, Pihusch R, Wilmanns W et al. Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinaemia after bone marrow transplantation. Blood 1997; 89: 2184\u20132188.","journal-title":"Blood"},{"key":"BF1705696_CR6","first-page":"3599","volume":"92","author":"E Carreras","year":"1998","unstructured":"Carreras E, Bertz H, Arcese W, Vernant JP, Tomas JF, Hagglund H et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukaemia Working Party. Blood 1998; 92: 3599\u20133604.","journal-title":"Blood"},{"key":"BF1705696_CR7","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","volume":"100","author":"T Ruutu","year":"2002","unstructured":"Ruutu T, Eriksson B, Remes K, Juvoven E, Volin L, Remberger M et al. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 2002; 100: 1977\u20131983.","journal-title":"Blood"},{"key":"BF1705696_CR8","first-page":"737","volume":"92","author":"PG Richardson","year":"1998","unstructured":"Richardson PG, Elias AD, Krishnan A, Wheeler C, Nath R, Hoppensteadt D et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population. Blood 1998; 92: 737\u2013744.","journal-title":"Blood"},{"key":"BF1705696_CR9","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1046\/j.1365-2141.2000.02475.x","volume":"111","author":"R Chopra","year":"2000","unstructured":"Chopra R, Eaton JD, Grassi A, Potter M, Shaw B, Salat C et al. Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study. Br J Haematol 2000; 111: 1122\u20131129.","journal-title":"Br J Haematol"},{"key":"BF1705696_CR10","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","volume":"100","author":"PG Richardson","year":"2002","unstructured":"Richardson PG, Murakami C, Jin Z, Warren E, Momtaz P, Hoppensteadt D et al. Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high risk population and factors predictive of outcome. Blood 2002; 100: 4337\u20134343.","journal-title":"Blood"},{"key":"BF1705696_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","volume":"33","author":"S Corbacioglu","year":"2004","unstructured":"Corbacioglu S, Greil J, Peters C, Wulffraat N, Laws HJ, Dilloo D et al. Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004; 33: 189\u2013195.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705696_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood-2004-10-4097","volume":"106","author":"PG Richardson","year":"2005","unstructured":"Richardson PG, Soiffer RJ, Antin JH, Jin Z, Kurtzberg J, Martin PL et al. Defibrotide for the treatment of veno-occlusive disease and multi-system organ failure post SCT: analysis of response and survival according to degree and type of MOF. Blood 2005; 106: 11 (abstract 399).","journal-title":"Blood"},{"key":"BF1705696_CR13","first-page":"795","volume":"91","author":"U Haussmann","year":"2006","unstructured":"Haussmann U, Fischer J, Eber S, Scherer F, Seger R, Gungor T et al. Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III\/defibrotide therapy. Haematologica 2006; 91: 795\u2013800.","journal-title":"Haematologica"},{"key":"BF1705696_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/sj.bmt.1705297","volume":"37","author":"H Imran","year":"2006","unstructured":"Imran H, Tleyjeh IM, Zirakzadeh A, Rodriguez V, Khan SP . Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis. Bone Marrow Transplant 2006; 37: 677\u2013686.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705696_CR15","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/j.1365-2141.1993.tb03152.x","volume":"84","author":"S Bearman","year":"1993","unstructured":"Bearman S, Shen DD, Hinds MS, Hill HA, McDonald G . A phase I\/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation. Br J Haematol 1993; 84: 724\u2013730.","journal-title":"Br J Haematol"},{"key":"BF1705696_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/(SICI)1096-8652(200005)64:1<32::AID-AJH6>3.0.CO;2-N","volume":"64","author":"K Ohasi","year":"2000","unstructured":"Ohasi K, Tanabe J, Watanbe R, Tanaka T, Sakamahi H, Maruta A et al. The Japanese multicenter open randomised trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation. Am J Hematol 2000; 64: 32\u201338.","journal-title":"Am J Hematol"},{"key":"BF1705696_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.bbmt.2004.01.002","volume":"10","author":"Y Chalandon","year":"2004","unstructured":"Chalandon Y, Roosnek E, Mermillod B, Newton A, Ozsabin H, Wacker P et al. Prevention of veno-occlusive disease with defibrotide after allogenic stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 347\u2013354.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF1705696_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.bmt.1705485","volume":"38","author":"S Corbacioglu","year":"2006","unstructured":"Corbacioglu S, Honig M, Lahr G, Stohr S, Berry G, Friedrich W et al. Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide. Bone Marrow Transplant 2006; 38: 547\u2013553.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705696_CR19","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/00007890-198712000-00011","volume":"44","author":"RJ Jones","year":"1987","unstructured":"Jones RJ, Lee KSK, Beschorner WE, Vogel VG, Grochow LB, Braine HB et al. Venocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778\u2013783.","journal-title":"Transplantation"},{"key":"BF1705696_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/0091270005283837","volume":"46","author":"K Tan","year":"2006","unstructured":"Tan K, Brayshaw N, Tomaszewski K, Troke P, Wood N . Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse effects or liver function test abnormalities. J Clin Pharmacol 2006; 46: 235\u2013243.","journal-title":"J Clin Pharmacol"},{"key":"BF1705696_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1046\/j.1365-2125.1999.00095.x","volume":"48","author":"LAG Rodriguez","year":"1999","unstructured":"Rodriguez LAG, Duque A, Castellsague J, Perez-Gutthann S, Stricker BHCh . A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. J Clin Pharmacol 1999; 48: 847\u2013852.","journal-title":"J Clin Pharmacol"},{"key":"BF1705696_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","volume":"129","author":"RJ Andrade","year":"2005","unstructured":"Andrade RJ, Lucena MI, Fernandez MC, Palaez G, Pachkena K, Garcia-Ruiz E et al. Drug induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10 year period. Gastroenterology 2005; 129: 512\u2013521.","journal-title":"Gastroenterology"},{"key":"BF1705696_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1200\/JCO.1993.11.2.304","volume":"11","author":"JP Radich","year":"1993","unstructured":"Radich JP, Sanders JE, Buckner CD, Martin PJ, Petersen FB, Bensinger W et al. Second allogeneic marrow transplantation for patients with recurrent leukaemia after initial transplant with total-body irradiation-containing regimens. J Clin Oncol 1993; 11: 304\u2013313.","journal-title":"J Clin Oncol"},{"key":"BF1705696_CR24","first-page":"1396","volume":"90","author":"S Cesaro","year":"2005","unstructured":"Cesaro S, Pillon M, Talenti E, Toffolutti T, Calore E, Tridello G et al. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation. Haematologica 2005; 90: 1396\u20131404.","journal-title":"Haematologica"},{"key":"BF1705696_CR25","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1182\/blood-2004-02-0414","volume":"104","author":"M De Lima","year":"2004","unstructured":"De Lima M, Couriel D, Thall PF, Wang X, Madden T, Jones R et al. Once-daily busulphan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Blood 2004; 104: 857\u2013864.","journal-title":"Blood"},{"key":"BF1705696_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/sj.bmt.1704166","volume":"32","author":"K Van Besien","year":"2003","unstructured":"Van Besien K, Devine S, Wickrema A, Jessop E, Amin K, Yassine M et al. Regimen-toxicity after fludarabine-melphalan conditioning: a prospective study of 31 patients with hematologic malignancies. Bone Marrow Transplant 2003; 32: 471\u2013476.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705696.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705696","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705696.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:37:23Z","timestamp":1648082243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,14]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["BF1705696"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705696","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,14]]},"assertion":[{"value":"9 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}